恩帕吉菲
2型糖尿病
医学
肌酐
肾脏疾病
蛋白尿
肾功能
糖尿病
泌尿科
置信区间
内科学
内分泌学
作者
Rajiv Agarwal,Jennifer B. Green,Hiddo J.L. Heerspink,Johannes F.E. Mann,Janet B. McGill,Amy K. Mottl,Julio Rosenstock,Peter Rossing,Muthiah Vaduganathan,Meike Brinker,Robert Edfors,Na Li,Markus F. Scheerer,Charlie Scott,Masaomi Nangaku
标识
DOI:10.1056/nejmoa2410659
摘要
Among persons with both chronic kidney disease and type 2 diabetes, initial therapy with finerenone plus empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either treatment alone. (Funded by Bayer; CONFIDENCE ClinicalTrials.gov number, NCT05254002.).
科研通智能强力驱动
Strongly Powered by AbleSci AI